Comfort Inn
Martinsburg, West Virginia, 25401, United States
NCT Number: NCT01262170
A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke
Looking for future studies?
Notify Me23 year–72 year
All sexes
Interventional
Phase 1
Martinsburg, West Virginia, 25401, United States
Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
lozenge made of dietary supplements
lozenge made of compressed cured tobacco extract
Time frame: 4 hours
craving is assessed by changes in questionnaire answers over time
Time frame: 5 hours
Rock Creek Pharmaceuticals, Inc.
Industry
A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03496077
Behavior, Chemically-Induced Disorders
Farmington, Connecticut, United States
View Trial DetailsNCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT01691105
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT02506829
Behavior, Chemically-Induced Disorders
New York, United States
View Trial Details